2017 MIPS Measure #444: Medication Management for People with Asthma

Valid Data Submission Method(s) Measure Type High Priority Measure? NQS Domain Specialty Measure Sets
Registry Process Yes Efficiency and Cost Reduction Allergy/Immunology, General Practice/Family Medicine, Pediatrics

Measure Description

The percentage of patients 5-64 years of age during the measurement year who were identified as having persistent asthma and were dispensed appropriate medications that they remained on for at least 75% of their treatment period

Instruction

This measure is to be reported a minimum of once per performance period for patients with a diagnosis of persistent asthma seen during the performance period. This measure may be reported by eligible clinicians who perform the quality actions described in the measure based on the services provided and the measure-specific denominator coding.

Denominator

Patients 5-64 years of age with persistent asthma and a visit during the measurement period

DENOMINATOR NOTE: *Signifies that this CPT Category I code is a non-covered service under the Medicare Part B Physician Fee Schedule (PFS). These non-covered services should be counted in the denominator population for registry-based measures.

Denominator Criteria (Eligible Cases):
Patients aged 5-64 years on date of encounter
AND
Diagnosis for persistent asthma (ICD-10-CM): J45.30, J45.31, J45.32, J45.40, J45.41, J45.42, J45.50, J45.51, J45.52
AND
Patient encounter during the performance period (CPT): 99201, 99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215, 99341, 99342, 99343, 99344, 99345, 99347, 99348, 99349, 99350, 99381*, 99382*, 99383*, 99384*, 99385*, 99386*, 99387*, 99391*, 99392*, 99393*, 99394*, 99395*, 99396*, 99397*
AND NOT
DENOMINATOR EXCLUSIONS:
Diagnosis of COPD, Emphysema, Obstructive Chronic Bronchitis, Chronic Respiratory Conditions Due to Fumes/Vapors, Cystic Fibrosis, or Acute Respiratory Failure any time during the patient’s history through the end of the measurement year: E84.0, E84.11, E84.19, E84.8, E84.9, J43.0, J43.1, J43.2, J43.8, J43.9, J44.0, J44.1, J44.9, J68.4, J96.00, J96.01, J96.02, J96.20, J96.21, J96.22, J98.2, J98.3
OR
Any patients who had no asthma controller medications dispensed during the measurement year: G9808
OR
Patients who use hospice services any time during the measurement period: G9809

Numerator

The number of patients who achieved a proportion of days (PDC) of at least 75% for their asthma controller medications during the measurement year

Definition:
PDC– The proportion of days covered by at least one asthma controller medication prescription, divided by the number of days in the treatment period. The treatment period is the period of time beginning on the earliest prescription dispensing date for any asthma controller medication during the measurement year through the last day of the measurement year.

Table MMA-B: Asthma Controller Medications

Description

 Prescriptions

 

 

Antiasthmatic combinations

  • Dyphylline-guaifenesin
  • Guaifenesin-theophylline
 

 

Antibody inhibitor

  • Omalizumab

 

 

Inhaled steroid combinations

  • Budesonide-formoterol
  • Fluticasone-salmeterol
  • Mometasone-formoterol
   

Inhaled corticosteroids

  • Beclomethasone
  • Budesonide
  • Ciclesonide
  • Flunisolide
  • Fluticasone CFC free
  • Mometasone
   

Leukotriene modifiers

  • Montelukast
  • Zafirlukast
  • Zileuton
   

Mast cell stabilizers

  • Cromolyn

 

 

Methylxanthines

  • Aminophylline
  • Dyphylline
  • Theophylline
   

Numerator Options:
Performance Met: Patient achieved a PDC of at least 75% for their asthma controller medication (G9810)
OR
Performance Not Met: Patient did not achieve a PDC of at least 75% for their asthma controller medication (G9811)

Stay up to date with the latest news regarding MACRA and MIPS.

The Healthmonix Advisor is a free weekly news source, connecting you to the latest updates in the value-based care industry.